Extracellular neuritic plaques, composed of aggregated amyloid-β (Aβ) peptides, are one of
the major histopathological hallmarks of Alzheimer's disease (AD), a progressive …

Alzheimer's disease (AD) is a complex multifactorial neurodegenerative disorder believed to
be initiated by accumulation of amyloid β (Aβ)-related peptides derived from proteolytic …

Objectives. Aluminium, a neurotoxic agent in humans, has been implicated in the
pathogenesis of neurodegenerative disorders. In this study, we examined the behavioral …

Alzheimer's disease (AD) is a devastating neurodegenerative disorder currently affecting
over 35 million people worldwide. Pathological hallmarks of AD are massive amyloidosis …

Alzheimer's disease (AD) is the most common type of dementias and becoming a worldwide
problem. As the time goes by, more and more researches show that AD is related to …

Inflammatory damage aggravates the progression of Alzheimer's disease (AD) and the
mechanism of inflammatory damage may provide a new therapeutic window for the …

In the present study we investigated the effect of the non-alcoholic fatty liver disease
(NAFLD) on the alterations in the activity of neurotransmitters catabolizing enzymes and …

Sažetak Statins are known to affect brain function in a manner not related to their
dyslipidemic effects. The purpose of the present study was to assess the behavioral …

Statins used to treat dyslipidemia may differentially modulate cholinesterase (ChE) activity
impacting neuronal function. This study examines the effects of three statins (atorvastatin …

Materials and Methods: Two hours after vehicle (control) or statin dosing at 250, 500, 750, or
1000 mg/kg orally, each mouse was subjected to 5 min open-field activity, negative geotaxis …